San Diego, CA, United States of America

Zhe Li Bounaud

This inventor holds 2 USPTO granted patents. Top assignee: Sgx Pharmaceuticals, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhe Li Bounaud. Retrieved from https://idiyas.com/inventor/zhe-li-bounaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhe Li Bounaud: Innovator in Pyrrolo-Pyridine Kinase Modulators

Introduction

Zhe Li Bounaud is a notable inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel pyrrolo-pyridine kinase modulators. With a total of two patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Zhe Li Bounaud's latest patents focus on pyrrolo-pyridine kinase modulators. The first patent presents novel pyrrolo-pyridine kinase modulators and outlines methods for using these compounds to treat diseases mediated by kinase activity. The second patent reiterates this innovative approach, emphasizing the potential of these modulators in therapeutic applications.

Career Highlights

Zhe Li Bounaud is currently associated with Sgx Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing critical health challenges through her inventions.

Collaborations

Some of her notable coworkers include William D Arnold and Pierre-Yves Bounaud. Their collaborative efforts contribute to the dynamic research environment at Sgx Pharmaceuticals, Inc.

Conclusion

Zhe Li Bounaud is a pioneering inventor whose work on pyrrolo-pyridine kinase modulators holds promise for the treatment of various diseases. Her contributions to biotechnology are significant and continue to influence the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…